Klotho Capital Stock from 2010 to 2026

KLTO Stock   0.29  0  1.03%   
Klotho Neurosciences Capital Stock yearly trend continues to be very stable with very little volatility. Capital Stock is likely to drop to 2,315. Capital Stock is the total amount of a company's capital funded by shareholders through the issue and subscription of shares. View All Fundamentals
 
Capital Stock  
First Reported
2010-12-31
Previous Quarter
2.4 K
Current Value
2.3 K
Quarterly Volatility
193.7 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Klotho Neurosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Klotho Neurosciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 730.5 K, Selling General Administrative of 6.7 M or Selling And Marketing Expenses of 598, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 8.6. Klotho financial statements analysis is a perfect complement when working with Klotho Neurosciences Valuation or Volatility modules.
  
Build AI portfolio with Klotho Stock
Check out the analysis of Klotho Neurosciences Correlation against competitors.
To learn how to invest in Klotho Stock, please use our How to Invest in Klotho Neurosciences guide.

Latest Klotho Neurosciences' Capital Stock Growth Pattern

Below is the plot of the Capital Stock of Klotho Neurosciences over the last few years. It is the total amount of a company's capital funded by shareholders through the issue and subscription of shares. Klotho Neurosciences' Capital Stock historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Klotho Neurosciences' overall financial position and show how it may be relating to other accounts over time.
Capital Stock10 Years Trend
Very volatile
   Capital Stock   
       Timeline  

Klotho Capital Stock Regression Statistics

Arithmetic Mean125,015
Geometric Mean47,801
Coefficient Of Variation154.90
Mean Deviation86,044
Median104,991
Standard Deviation193,652
Sample Variance37.5B
Range854.9K
R-Value0.02
Mean Square Error40B
R-Squared0.0005
Significance0.93
Slope821.64
Total Sum of Squares600B

Klotho Capital Stock History

2026 2315.34
2025 2437.2
2024 2708.0
2023 1513.0
2022856.4 K

Other Fundumenentals of Klotho Neurosciences

Klotho Neurosciences Capital Stock component correlations

About Klotho Neurosciences Financial Statements

Klotho Neurosciences investors utilize fundamental indicators, such as Capital Stock, to predict how Klotho Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Capital Stock2.4 K2.3 K
Issuance Of Capital Stock265.5 K259 K

Pair Trading with Klotho Neurosciences

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Klotho Neurosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Klotho Neurosciences will appreciate offsetting losses from the drop in the long position's value.

Moving together with Klotho Stock

  0.73LEXX Lexaria Bioscience CorpPairCorr
  0.79LIXT Lixte BiotechnologyPairCorr

Moving against Klotho Stock

  0.76CING CingulatePairCorr
  0.65OABI OmniAb IncPairCorr
  0.65PPERY Bank Mandiri Persero Earnings Call This WeekPairCorr
  0.57PEPG PepGenPairCorr
  0.35MOLN Molecular PartnersPairCorr
The ability to find closely correlated positions to Klotho Neurosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Klotho Neurosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Klotho Neurosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Klotho Neurosciences to buy it.
The correlation of Klotho Neurosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Klotho Neurosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Klotho Neurosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Klotho Neurosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Klotho Neurosciences is a strong investment it is important to analyze Klotho Neurosciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Klotho Neurosciences' future performance. For an informed investment choice regarding Klotho Stock, refer to the following important reports:
Check out the analysis of Klotho Neurosciences Correlation against competitors.
To learn how to invest in Klotho Stock, please use our How to Invest in Klotho Neurosciences guide.
You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Will Biotechnology sector continue expanding? Could Klotho diversify its offerings? Factors like these will boost the valuation of Klotho Neurosciences. Expected growth trajectory for Klotho significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Klotho Neurosciences data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(0.30)
Return On Assets
(0.72)
Return On Equity
(1.98)
The market value of Klotho Neurosciences is measured differently than its book value, which is the value of Klotho that is recorded on the company's balance sheet. Investors also form their own opinion of Klotho Neurosciences' value that differs from its market value or its book value, called intrinsic value, which is Klotho Neurosciences' true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Klotho Neurosciences' market value can be influenced by many factors that don't directly affect Klotho Neurosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Klotho Neurosciences' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Klotho Neurosciences represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Klotho Neurosciences' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.